Protagenic Therapeutics, Inc.\new (PTIX) Total liabilities 2017–2026
Protagenic Therapeutics, Inc.\new (PTIX) total liabilities at each fiscal year-end, per SEC filings.
$1.0MFY2026 · since FY2017: $684,857 → $1.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $1.0M | -79.5% |
| FY2025 | $5.0M | +669.5% |
| FY2024 | $655,252 | -41.5% |
| FY2023 | $1.1M | +0.2% |
| FY2022 | $1.1M | -44.9% |
| FY2021 | $2.0M | — |
| FY2017 | $684,857 | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice